Showing 1 - 10 of 3,347
We provide a theoretical framework to contribute to the current debate regarding the tendency of pharmaceutical companies to direct their R&D toward marketing products that are "follow-on" drugs of already existing drugs, rather than toward the development of breakthrough drugs. We construct a...
Persistent link: https://www.econbiz.de/10011406575
Persistent link: https://www.econbiz.de/10014227886
suggestive evidence that the opioid pandemic hinders local firms’ innovation by increasing their health care costs and by …
Persistent link: https://www.econbiz.de/10014236623
Persistent link: https://www.econbiz.de/10011894661
Persistent link: https://www.econbiz.de/10009706220
Persistent link: https://www.econbiz.de/10012801454
pharmaceuticals. It is expected that this technology will bring new solutions to address fundamental global health problems. However … reconfiguration of drug delivery systems wherein new products are being developed for administering pharmaceuticals inside the body … academic communities are devoting important efforts toward the advancement of AM in the health industry, especially …
Persistent link: https://www.econbiz.de/10012438414
Persistent link: https://www.econbiz.de/10011819034
Persistent link: https://www.econbiz.de/10001207091
Persistent link: https://www.econbiz.de/10011482947